UnitedHealth Group (UNH) Q3 FY2025 income statement Sankey chart
Source: 10-Q · filed 2025-10-28 · SEC EDGAR · GAAP

UnitedHealth Group (UNH) Q3 FY2025 (quarter ended 2025-09-30): revenue $113.2B (+12% Y/Y), operating income $4.3B, net income $2.3B (2% margin). Sankey chart of where the money comes from and goes, from the 10-Q filed 2025-10-28.
How to read this chart
Left: revenue sources flowing into revenue. This company does not report a separate cost of revenue or gross profit, so revenue splits straight into operating expenses (red) and operating profit (green). Wider band = bigger amount; "Y/Y" = vs. a year earlier.
- Out of every 100 dollars of revenue, 2.1 dollars ended up as net profit.
- The biggest single cost is Medical Costs: $80.0B, or 71% of revenue.
- Operating margin 3.8%, down 4.8 percentage points from a year earlier (8.6%).
Worth noting
- Operating income -50% Y/Y
- Pre-tax income -58% Y/Y
- Net income -61% Y/Y
Cash flow
Operating cash flow $5.9B, capex $0.9B, free cash flow (derived = OCF − capex) $5.1B.
Key figures
| Item | Q3 FY2025 | Prior year | Y/Y | % of revenue |
|---|---|---|---|---|
| Revenue | $113.2B | $100.8B | +12% | — |
| Operating expenses | $108.8B | $92.1B | +18% | 96.2% |
| Operating income | $4.3B | $8.7B | -50% | 3.8% |
| Net income | $2.3B | $6.1B | -61% | 2.1% |
Source: UnitedHealth Group Form 10-Q filed Oct 28, 2025 (accession 0000731766-25-000305) via SEC EDGAR · Q3 FY25 = quarter ended Sep 30, 2025 · GAAP, as reported · Y/Y vs. prior-year period · Note: (±N pp) = change vs the prior-year period in percentage points · Not investment advice / 不构成投资建议 · Created 2026-10-24 · OneChart Earnings · onechartearnings.com
UnitedHealth Group · Quarters
UnitedHealth Group · Fiscal years
Earlier periods (not generated yet — press Generate, about 1–2 min) · 80
Back to 2009 (the SEC XBRL era). Each visitor can generate 3 periods a day and the whole site 30 a day; beyond that, requests are queued for the next day. Generated charts are kept permanently.
Quarters
- Q2 FY2025
- Q1 FY2025
- Q4 FY2024
- Q3 FY2024
- Q2 FY2024
- Q1 FY2024
- Q4 FY2023
- Q3 FY2023
- Q2 FY2023
- Q1 FY2023
- Q4 FY2022
- Q3 FY2022
- Q2 FY2022
- Q1 FY2022
- Q4 FY2021
- Q3 FY2021
- Q2 FY2021
- Q1 FY2021
- Q4 FY2020
- Q3 FY2020
- Q2 FY2020
- Q1 FY2020
- Q4 FY2019
- Q3 FY2019
- Q2 FY2019
- Q1 FY2019
- Q4 FY2018
- Q3 FY2018
- Q2 FY2018
- Q1 FY2018
- Q4 FY2017
- Q3 FY2017
- Q2 FY2017
- Q1 FY2017
- Q4 FY2016
- Q3 FY2016
- Q2 FY2016
- Q1 FY2016
- Q4 FY2015
- Q3 FY2015
- Q2 FY2015
- Q1 FY2015
- Q4 FY2014
- Q3 FY2014
- Q2 FY2014
- Q1 FY2014
- Q4 FY2013
- Q3 FY2013
- Q2 FY2013
- Q1 FY2013
- Q4 FY2012
- Q3 FY2012
- Q2 FY2012
- Q1 FY2012
- Q4 FY2011
- Q3 FY2011
- Q2 FY2011
- Q1 FY2011
- Q4 FY2010
- Q3 FY2010
- Q2 FY2010
- Q1 FY2010
- Q4 FY2009
- Q3 FY2009
- Q2 FY2009
Fiscal years
- FY2023
- FY2022
- FY2021
- FY2020
- FY2019
- FY2018
- FY2017
- FY2016
- FY2015
- FY2014
- FY2013
- FY2012
- FY2011
- FY2010
- FY2009